Altasciences is pleased to welcome Dr. William J. Foster, MD, PhD, FRCSC, to the Altasciences family as Principal Investigator and Consultant on clinical trials.
Altasciences announced today that construction work has begun on the expansion of their ligand binding laboratory to meet the high demand for quality bioanalytical services.
Altasciences announced today that it has signed a definitive agreement to acquire the preclinical testing business of SNBL U.S.A.
Altasciences’ Chris Perkin Honored as One of 100 Most Inspiring Leaders in the Life Sciences Industry
Altasciences, a leading North American early phase contract research organization (CRO), is pleased to announce that, for a fourth consecutive year, CEO Chris Perkin has been honored as one of the 100 Most Inspiring Leaders in the Life Sciences Industry by PharmaVOICE magazine.
Altasciences is pleased to have partnered with Xeris Pharmaceuticals on a study to evaluate the efficacy and safety of their investigational glucagon injection in Type 1 diabetes mellitus (T1D) subjects.